A Randomized Trial of Ketorolac vs Sumatripan vs Placebo Nasal Spray (KSPN) for Acute Migraine

To compare the efficacy of ketorolac nasal spray (NS) vs placebo and sumatriptan NS for the acute treatment of migraine.

[1]  S. Silberstein,et al.  The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies , 2015, Headache.

[2]  S. Tepper,et al.  Intranasal Zolmitriptan for the Treatment of Acute Migraine , 2013, Headache.

[3]  B. Rowe,et al.  Ketorolac in the Treatment of Acute Migraine: A Systematic Review , 2013, Headache.

[4]  E. Hersh,et al.  A review of intranasal ketorolac tromethamine for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level , 2012, Current medical research and opinion.

[5]  M. Färkkilä,et al.  Intranasal ketorolac tromethamine (SPRIX®) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: Safety and efficacy data from a phase II clinical trial , 2012, Cephalalgia.

[6]  S. Silberstein,et al.  Efficacy and Safety of MAP0004, Orally Inhaled DHE in Treating Migraines With and Without Allodynia , 2012, Headache.

[7]  Min Yang,et al.  Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine , 2011, Cephalalgia : an international journal of headache.

[8]  L. Bynum,et al.  Intranasal ketorolac for postoperative pain: a phase 3, double-blind, randomized study. , 2009, Pain medicine.

[9]  S. Silberstein,et al.  Improved Identification of Allodynic Migraine Patients Using a Questionnaire , 2007, Cephalalgia : an international journal of headache.

[10]  R. Lipton,et al.  The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide , 2007, Cephalalgia : an international journal of headache.

[11]  S. Silberstein,et al.  Can allodynic migraine patients be identified interictally using a questionnaire? , 2005, Neurology.

[12]  R. Burstein,et al.  Defeating migraine pain with triptans: A race against the development of cutaneous allodynia , 2004, Annals of neurology.

[13]  Jes Olesen,et al.  The International Classification of Headache Disorders: 2nd edition. , 2004, Cephalalgia : an international journal of headache.

[14]  W. Becker,et al.  Sumatriptan nasal spray: a dose‐ranging study in the acute treatment of migraine , 1999, European journal of neurology.

[15]  M. Asgharnejad,et al.  Sumatriptan nasal spray for the acute treatment of migraine , 1997, Neurology.